References

Chawla A, Chawla R, Jaggi S Microvasular and macrovascular complications in diabetes mellitus: Distinct or continuum?. Indian J Endocrinol Metab.. 2016; 20:(4)546-551 https://doi.org/10.4103/2230-8210.183480

Counterweight. Counterweight's Diabetes Remission Plus Programme extended to all of Wales this year. 2022. https//www.counterweight.org/blogs/news-and-media/counterweight-s-diabetes-remission-plus-programme-extended-to-all-of-wales-this-year (accessed 23 January 2024)

Diabetes UK. How many people in the UK have diabetes?. 2023a. https//www.diabetes.org.uk/professionals/position-statements-reports/statistics (accessed 23 January 2024)

Diabetes UK. Diabetes is serious. Diabetes UK. 2023c. https//www.diabetes.org.uk/get_involved/campaigning/diabetes-is-serious (accessed 23 January 2024)

Dong W, Zhang S, Yan S, Zhao Z, Zhang Z, Gu W Clinical characteristics of patients with early-onset diabetes mellitus: a single-center retrospective study. BMC Endocr Disord. 2023; 23:(1) https://doi.org/10.1186/s12902-023-01468-2

Drugs.com. How long does metformin take to work. 2023. https//www.drugs.com/medical-answers/how-long-metformin-take-work-3574615/ (accessed 23 January 2024)

Life expectancy associated with different ages at diagnosis of type 2 diabetes in high-income countries: 23 million person-years of observation. Lancet Diabetes Endocrinol.. 2023; 11:(10)731-742 https://doi.org/10.1016/S2213-8587(23)00223-1

Hermann M, Heimro LS, Haugstvedt A, Hernar I, Sigurdardottir AK, Graue M Hypoglycaemia in older home-dwelling people with diabetes-a scoping review. BMC Geriatr. 2021; 21:(1) https://doi.org/10.1186/s12877-020-01961-6

Khunti K, Aroda VR, Aschner P The impact of the COVID-19 pandemic on diabetes services: planning for a global recovery. Lancet Diabetes Endocrinol.. 2022; 10:(12)890-900 https://doi.org/10.1016/S2213-8587(22)00278-9

Kyle RG, Wills J, Mahoney C, Hoyle L, Kelly M, Atherton IM Obesity prevalence among healthcare professionals in England: a cross-sectional study using the Health Survey for England. BMJ Open. 2017; 7:(12) https://doi.org/10.1136/bmjopen-2017-018498

Lean ME, Leslie WS, Barnes AC Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. Lancet. 2018; 391:(10120)541-551 https://doi.org/10.1016/S0140-6736(17)33102-1

Magliano DJ, Sacre JW, Harding JL, Gregg EW, Zimmet PZ, Shaw JE Young-onset type 2 diabetes mellitus - implications for morbidity and mortality. Nat Rev Endocrinol.. 2020; 16:(6)321-331 https://doi.org/10.1038/s41574-020-0334-z

McCombie L, Leslie W, Taylor R, Kennon B, Sattar N, Lean MEJ Beating type 2 diabetes into remission. BMJ. 2017; 358 https://doi.org/10.1136/bmj.j4030

Medline Plus. Hemoglobin a1c (Hba1c). 2021. https//medlineplus.gov/lab-tests/hemoglobin-a1c-hba1c-test/ (accessed 23 January 2024)

Misra A Ethnic-specific criteria for classification of body mass index: a perspective for Asian Indians and American Diabetes Association Position Statement. Diabetes Technol Ther.. 2015; 17:(9)667-671 https://doi.org/10.1089/dia.2015.0007

NHS England. NHS Type 2 Diabetes Path to Remission Programme. 2023a. https//www.england.nhs.uk/diabetes/treatment-care/low-calorie-diets/ (accessed 23 January 2024)

NHS England. Digital weight management programme for NHS staff. Supporting our NHS colleagues through a digital weight management programme for staff. 2023b. https//www.england.nhs.uk/supporting-our-nhs-people/support-now/digital-weight-management-programme-for-nhs-staff/ (accessed 23 January 2024)

NHS England. NHS soups and shakes diet helps thousands shed the pounds. 2022. https//www.england.nhs.uk/2022/01/nhs-soups-and-shakes-diet-helps-thousands-shed-the-pounds/ (accessed 23 January 2024)

NHS Lanarkshire. Type 2 Diabetes Remission Programme (using Counterweight Plus®). 2023. https//www.nhslanarkshire.scot.nhs.uk/services/diabetes/type-2-diabetes-remission-programme-using-counterweight-plus/ (accessed 23 January 2024)

Type 2 diabetes: how to manage and treat the condition well. 2023. https//www.nursingtimes.net/clinical-archive/diabetes-clinical-archive/type-2-diabetes-how-to-manage-and-treat-the-condition-well-06-11-2023/ (accessed 23 January 2024)

Nazarko L Diabetes care prevalence and types. Br J Health Assist.. 2016; 10:(7)317-362 https://doi.org/10.12968/bjha.2016.10.7.323

National Institute for Health and Care Excellence. Obesity: identification, assessment and management Clinical guideline [CG189]. 2014. https//www.nice.org.uk/guidance/cg189/chapter/Recommendations#identifying-and-assessing-overweight-obesity-and-central-adiposity (accessed 23 January 2024)

National Institute for Health and Care Excellence. Type 2 Diabetes in Adults: Management. 2022. https//www.nice.org.uk/guidance/ng28 (accessed 23 January 2024)

National Institute for Health and Care Excellence. Diabetes – type 2. When should I suspect type 2 diabetes in an adult?. 2023a. https//cks.nice.org.uk/topics/diabetes-type-2/diagnosis/diagnosis-in-adults/ (accessed 23 January 2024)

National Institute for Health and Care Excellence. Diabetes – type 2: Prescribing information. 2023b. https//bnf.nice.org.uk/drugs/metformin-hydrochloride/ (accessed 23 January 2024)

National Institute for Health and Care Excellence. Diabetes - type 2: Sulfonylureas. 2023c. https//cks.nice.org.uk/topics/diabetes-type-2/prescribing-information/sulfonylureas/ (accessed 23 January 2024)

National Institute for Health and Care Excellence. Diabetes - type 2: SGLT-2inhibitors. 2023d. https//cks.nice.org.uk/topics/diabetes-type-2/prescribing-information/sglt-2-inhibitors/ (accessed 23 January 2024)

Pitts-Tucker T Asian and Afro-Caribbean Britons have double the risk of type 2 diabetes. BMJ. 2012; 345 https://doi.org/10.1136/bmj.e6135

Romieu I, Dossus L, Barquera S IARC working group on Energy Balance and Obesity. Energy balance and obesity: what are the main drivers?. Cancer Causes Control.. 2017; 28:(3)247-258 https://doi.org/10.1007/s10552-017-0869-z

Sadali UB, Kamal KKBN, Park J, Chew HSJ, Devi MK The global prevalence of overweight and obesity among nurses: A systematic review and meta-analyses. J Clin Nurs. 2023; 32:(23-24)7934-7955 https://doi.org/10.1111/jocn.16861

Convert HbA1c to average blood sugar level. 2023. https//www.diabetes.co.uk/hba1c-to-blood-sugar-level-converter.html (accessed 23 January 2024)

Stringhini S, Zaninotto P, Kumari M, Kivimäki M, Batty GD Lifecourse socioeconomic status and type 2 diabetes: the role of chronic inflammation in the English Longitudinal Study of Ageing. Scientific reports. 2016; 6 https://doi.org/10.1038/srep24780

Weir CB, Jan A BMI Classification Percentile And Cut Off Points.StatPearls. Treasure Island (FL): StatPearls Publishing; 2023

World Health Organization. Diabetes overview. 2021a. https//www.who.int/health-topics/diabetes#tab=tab_1 (accessed 23 January 2024)

World Health Organization. Diabetes. 2021b. https//www.who.int/news-room/fact-sheets/detail/diabetes (accessed 23 January 2024)

Zelniker TA, Wiviott SD, Raz I SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials. Lancet. 2019; 393:31-39 https://doi.org/10.1016/S0140-6736(18)32590-X

Zendjabil M Glycated albumin. Clin Chim Acta. 2020; 502:240-244 https://doi.org/10.1016/j.cca.2019.11.007

Type 2 diabetes post pandemic: enabling your patients to regain control

02 March 2024
Volume 29 · Issue 3

Abstract

There are now an estimated five million people living with diabetes in the UK, most have type 2 diabetes. The COVID-19 pandemic affected access to care, led to delays in diagnoses of diabetes and many people with diabetes experienced a deterioration in their diabetes control. This article provides guidance on how nurses can work with people at risk of diabetes to prevent diabetes, to induce remission and how to use medication to treat diabetes.

Over 4 million people in the UK are known to have diabetes mellitus. The most common form of diabetes is type 2, which is preventable and treatable (Diabetes UK, 2023a). Most people with type 2 diabetes are managed in primary care until complications develop (McCombie et. al, 2017). COVID-19 restricted access to routine diabetes care, limiting new diagnoses, affecting self-management, routine follow-ups, access to medications and affected lifestyle (Khunti et al, 2022). The lack of support has affected the ability of people with diabetes to manage their condition well (Diabetes UK, 2023b).

This article will explore the diagnosis and treatment of type 2 diabetes using a case history approach.

Diabetes is defined as:

‘…a chronic, metabolic disease characterised by elevated levels of blood glucose (or blood sugar), which leads over time to serious damage to the heart, blood vessels, eyes, kidneys and nerves.’

Register now to continue reading

Thank you for visiting Community Nursing and reading some of our peer-reviewed resources for district and community nurses. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Limited access to clinical or professional articles

  • New content and clinical newsletter updates each month